D. E. Shaw & Co., Inc. Opti Nose, Inc. Transaction History
D. E. Shaw & Co., Inc.
- $98.6 Billion
- Q2 2024
A detailed history of D. E. Shaw & Co., Inc. transactions in Opti Nose, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 5,000,000 shares of OPTN stock, worth $4.3 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,000,000Holding current value
$4.3 Million% of portfolio
0.01%Shares
11 transactions
Others Institutions Holding OPTN
# of Institutions
79Shares Held
85.2MCall Options Held
0Put Options Held
0-
Mvm Partners, LLC Boston, MA14.6MShares$12.6 Million15.07% of portfolio
-
Great Point Partners LLC Greenwich, CT13.7MShares$11.8 Million3.78% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT13.4MShares$11.5 Million0.93% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY5.6MShares$4.82 Million0.68% of portfolio
-
Black Rock Inc. New York, NY5.27MShares$4.54 Million0.0% of portfolio
About OptiNose, Inc.
- Ticker OPTN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 83,277,504
- Market Cap $71.6M
- Description
- OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...